nd.gov - The Official Portal for North Dakota State Government North Dakota: Legendary. Follow the trail of legends
Go to the Health Department home page

Program Areas

General Information

Multistate Fungal Meningitis Outbreak Investigation CDCpic
   
The Centers for Disease Control and Prevention (CDC) with state and local health departments and the Food and Drug Administration (FDA) are investigating a multistate meningitis outbreak of fungal infections among patients who have received a steroid injection of a potentially contaminated product into the spinal area. Several patients suffered strokes that are believed to have resulted from their infection. The investigation also includes fungal infections associated with injections in a peripheral joint space, such as a knee, shoulder or ankle. CDC and public health officials are referring any patients who have symptoms that suggest possible meningitis or a possible peripheral joint infection to their physicians who can evaluate them further. Those patients injected in peripheral joints only are not believed to be at risk for fungal meningitis but could be at risk for joint infection. For more information on the current situation click here.
   
North Dakota Department of Health - Health Alerts and News Releases CDCpic2
redbullet HAN - November 2, 2012
redbullet HAN - October 24, 2012
redbullet HAN - October 17, 2012
redbullet HAN - October 8, 2012
redbullet HAN - October 5, 2012
redbullet HAN - October 4, 2012
   
redbullet News Release - October 17, 2012
   
Centers for Disease Control and Prevention
redbullet What is Fungal Meningitis?
redbullet Patient Guidance - FAQs NDmap
North Dakota Data:
There are currently no cases in North Dakota
redbullet Clinician Guidance
  »   What Should Clinicians be Doing?
redbullet Current Outbreak Case Count
   
Food and Drug Administration (FDA)
redbullet List of Recalled Products
redbullet New England Compounding Center (NECC) Recall Letter (non-FDA link)
redbullet FDA MedWatch Safety Alert - NECC Products
redbullet Patient Notification Letter Template (pdf)
redbullet Health care professionals and patients may dial FDA’s Drug Information Line at 855-543-DRUG (3784) and press * to get the most recent information regarding the meningitis recall and speak directly to a pharmacist  
     
Reporting Cases  
redbullet Meningitis and Septic Arthritis Case Definition (CDC link)  
redbullet Suspect or concerning cases should be reported to the North Dakota Department of Health by calling 800.472.2180 or 701.328.2378  
redbullet Clinicians are also requested to report any suspected adverse events following use of NECC products to FDA's MedWatch program at 1-800-332-1088 or www.fda.gov/medwatch